Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Endocyte Inc (ECYT)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,010,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $23.99 - $23.99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 168
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Ritter Allen R VP of Manufacturing/CMC   •       –      –    2014-04-09 4 AS $21.16 $21,160 D/D (1,000) 11,722     -
   Ritter Allen R VP of Manufacturing/CMC   •       –      –    2014-03-21 4 AS $33.11 $264,880 D/D (8,000) 12,722     -
   Low Philip S Chief Science Officer   •       •      –    2014-03-13 4 GA $0.00 $0 I/I 1,520 193,318     -
   Low Philip S Chief Science Officer   •       •      –    2014-03-13 4 GD $0.00 $0 D/D 1,520 199,299     -
   Ellis P Ron President and CEO   •       •      –    2014-03-10 4 OE $1.91 $152,800 D/D 80,000 204,586     -
   Ellis P Ron President and CEO   •       •      –    2014-02-21 4 GD $0.00 $0 D/D 2,400 124,586     -
   Low Philip S Chief Science Officer   •       •      –    2014-02-14 4 AS $15.00 $90,000 D/D (6,000) 200,819     -
   Low Philip S Chief Science Officer   •       •      –    2014-02-11 4 OE $1.91 $1,910 D/D 1,000 206,819     -
   Taylor Beth Corporate Controller   •       –      –    2014-02-06 4 A $0.00 $0 D/D 5,425 7,147     -
   Sherman Michael A. Chief Financial Officer   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 80,798     -
   Brinkley Michael A. VP OF QUALITY   •       –      –    2014-02-06 4 A $0.00 $0 D/D 6,250 6,250     -
   Nguyen Binh VP of Medical Affairs   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 10,200     -
   Ellis P Ron President and CEO   •       •      –    2014-02-06 4 A $0.00 $0 D/D 22,500 51,654     -
   Harper Scot VP of CLINICAL OPERATIONS   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 7,500     -
   Lovejoy Chandra D VP of Regulatory Affairs   •       –      –    2014-02-06 4 A $0.00 $0 D/D 6,250 6,250     -
   Low Philip S Chief Science Officer   •       •      –    2014-02-06 4 A $0.00 $0 D/D 7,500 205,819     -
   Leamon Christopher P Vice President of Research   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 17,573     -
   Meek David D. Chief Commercial Officer   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 7,500     -
   Ritter Allen R VP of Manufacturing/CMC   •       –      –    2014-02-06 4 A $0.00 $0 D/D 5,000 20,722     -
   Low Philip S Chief Science Officer   •       •      –    2014-01-14 4 OE $1.91 $1,910 D/D 1,000 198,319     -
   Low Philip S Chief Science Officer   •       •      –    2013-12-17 4 OE $1.91 $1,910 D/D 1,000 197,319     -
   Ellis P Ron President and CEO   •       •      –    2013-12-04 4 OE $1.91 $5,730 D/D 3,000 29,154     -
   Ellis P Ron President and CEO   •       •      –    2013-12-02 4 AS $12.00 $36,000 D/D (3,000) 26,154     -
   Low Philip S Chief Science Officer   •       •      –    2013-11-12 4 OE $1.91 $1,910 D/D 1,000 196,319     -
   Ellis P Ron President and CEO   •       •      –    2013-11-07 4 OE $1.91 $5,730 D/D 3,000 29,154     -

  168 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed